ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Outcome"

  • 2019 American Transplant Congress

    Not All Poor Metabolizers Are Clinically Equal: Evaluating Weight-Based Tacrolimus Outcomes in CYP3A Loss of Function Variants

    A. Q. Maldonado, W. Irish, T. E. Asempa, J. Gooden, M. L. Davis, C. Haisch, H. Jones, D. Leeser, L. Rebellato

    Vidant Medical Center - Transplant Services, Greenville, NC

    *Purpose: CYP3A polymorphisms are an important pharmacotherapeutic consideration due to the extensive CYP metabolism of tacrolimus (TAC) and variable expression among different races. The CPIC…
  • 2019 American Transplant Congress

    A Randomized, Controlled, Trial of Interventions to Promote Walking after Abdominal Organ Transplantation: The LIFT Study

    M. Serper1, I. Barankay2, S. Chadha1, J. Shults3, P. Reese1

    1University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 2Wharton School, University of Pennsylvania, Philadelphia, PA, 3Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA

    *Purpose: Substantial weight gain and sedentary behavior are common after transplantation. Behavioral economic strategies with financial incentives and reminders may promote healthy behaviors in the…
  • 2019 American Transplant Congress

    Exosomes Carry Stress and Damage Specific miRNAs during Peritransplant Period in TPIAT

    P. Saravanan1, M. Kanak1, S. Vasu2, M. Lawrence2, M. Levy1, B. Naziruddin3

    1Department of Surgery, Virginia Commonwealth University, VCU Health, Richmond, VA, 2Islet Cell Lab, Baylor Scott and White Research Institute, Dallas, TX, 3Simmons Transplant Institute, Baylor Scott and White Medical Center, Dallas, TX

    *Purpose: Innate inflammation and hypoxia during peritransplant period significantly affect survival of islet grafts. Markers that can identify stress and/or damage during this early period…
  • 2019 American Transplant Congress

    Donor Derived Tuberculosis in Solid Organ Transplantation in the United States: 10 Years of UNOS Ad Hoc Disease Transmission Advisory Committee Experience

    M. F. Malinis1, R. LaHoz1, G. Vece2, S. Tlusty2, S. Aslam1, R. Bag1, J. Bucio1, L. Danziger-Isakov1, D. F. Florescu1, M. Rana1, C. Wolfe1, M. G. Michaels1

    1DTAC, Richmond, VA, 2UNOS, Richmond, VA

    *Purpose: Mycobacterium tuberculosis can be transmitted via organ donation. Failure to recognize tuberculosis (TB) may result in significant morbidity and mortality. Currently, donor screening for…
  • 2019 American Transplant Congress

    Outcomes of Renal Transplantation in Elderly Patients Older Than 60 Years of Age

    R. Yemini1, E. Nesher2, R. Rahamimov3, S. Eizner2, V. Mazhybovsky2, V. Tennak2, M. Gurevich2, R. Ghinea2, E. Mor2

    1Department of Surgery, Assuta Ashdod Medical Center, Ashdod, Israel, 2Department of Transplant Surgery, Beilinson Medical Center, Petach-Tikva, Israel, 3Department of Nephrology, Beilinson Medical Center, Petach-Tikva, Israel

    *Purpose: Patients ≥ 60 years are the largest growing age group which comprise 40% of all patients with ESRD. Kidney transplantation has been shown to…
  • 2019 American Transplant Congress

    Etiology of Liver Disease Affects Weight Gain after Liver Transplant

    A. Chandrakumaran1, M. B. Siddiqui2, S. Patel2, F. Lin3, J. Laurenzano2, J. Clinton2, T. Reichman4, C. Bhati4, M. S. Siddiqui2

    1Internal Medicine, Virginia Commonwealth University, Richmond, VA, 2Gastroenterology & Hepatology, Virginia Commonwealth University, Richmond, VA, 3Virginia Commonwealth University, Richmond, VA, 4Transplant Surgery, Virginia Commonwealth University, Richmond, VA

    *Purpose: Weight gain after liver transplant (LT) is a key driver of cardiometabolic disease and associated mortality. There is little known about trends in post-LT…
  • 2019 American Transplant Congress

    A National Cohort Validation of Graft Outcomes of Elderly Kidney Transplant Recipients

    I. Bajjoka, A. Yaldo, C. Crombez, M. Abouljoud

    Henry Ford Transplant Institute, Detroit, MI

    *Purpose: Previous analyses comparing elderly kidney transplant recipients (KTR) to younger KTR found that elderly patients suffered higher rates of mortality, less biopsy-proven acute rejection…
  • 2019 American Transplant Congress

    Impact of MELD-Na Course (Delta MELD-Na) on Outcome after Liver Transplantation

    G. Silberhumer1, G. Gyoeri1, L. Unger2, G. Harpain1

    1Transplant Surgery, Medical University Vienna, Vienna, Austria, 2Institute for Mathematics and Bioscience, Medical University Vienna, Vienna, Austria

    *Purpose: Currently, MELD Score listing is state of the art for liver transplant recipients. Our department could show by our own institutional data and confirmed…
  • 2019 American Transplant Congress

    Initial Single-Center Results from the Pilot Transplant Quality Improvement Project in Liver Transplant

    A. Zarinsefat, S. M. Syed, R. Hirose

    UC San Francisco, San Francisco, CA

    *Purpose: The National Surgical Quality Improvement Program (NSQIP) has been an effective measure in improving the quality of surgical care, while also providing data to…
  • 2019 American Transplant Congress

    Multicenter Experience Evaluating Outcomes of HCV-Seropositive Donors to HCV-Seronegative Recipients Liver Transplantation

    K. Wijarnpreecha1, B. Aqel2, S. Pungpapong1, C. Taner3, K. Reddy4, M. Leise5, R. Dickson2

    1Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, 2Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ, 3Transplant, Mayo Clinic, Jacksonville, FL, 4Transplant and Hepatobiliary Surgery, Mayo Clinic, Scottsdale, AZ, 5Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN

    *Purpose: Grafts from hepatitis C virus (HCV)-seropositive donors can now be considered for liver transplant (LT) due to the advent of direct-acting antiviral agents (DAA).…
  • « Previous Page
  • 1
  • …
  • 63
  • 64
  • 65
  • 66
  • 67
  • …
  • 155
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences